dc.contributor.author | Sahin, Alparslan | |
dc.contributor.author | Behnes, Michael | |
dc.contributor.author | Akin, Ibrahim | |
dc.contributor.author | Yildiz, Mustafa | |
dc.date.accessioned | 2021-03-03T15:53:38Z | |
dc.date.available | 2021-03-03T15:53:38Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Yildiz M., Sahin A., Behnes M., Akin I., "An Expanding Role of Biomarkers in Pulmonary Arterial Hypertension", CURRENT PHARMACEUTICAL BIOTECHNOLOGY, cilt.18, sa.6, ss.491-494, 2017 | |
dc.identifier.issn | 1389-2010 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_4155e5eb-709f-4f60-9562-5e2875af95d0 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/47651 | |
dc.identifier.uri | https://doi.org/10.2174/1389201018666170615082510 | |
dc.description.abstract | Background: Pulmonary Arterial Hypertension (PAH) is a chronic disease which may cause or result from multiple cardiopulmonary disorders. The disease has complex pathophysiological mechanisms and involves many systematic, cellular and molecular changes. Therefore, it is crucial to find out underlying mechanisms and detect biomarkers to achieve early and proper diagnosis, evaluating disease severity, for follow-up and monitor response to treatment. Many biomarkers for PAH have been investigated but yet no such biomarker has been found specific and easily accessible to use for the patients. This review aims to identify an expanding role of biomarkers in PAH. | |
dc.language.iso | eng | |
dc.subject | Drug Guides | |
dc.subject | Life Sciences | |
dc.subject | Health Sciences | |
dc.subject | Sitogenetik | |
dc.subject | BİYOKİMYA VE MOLEKÜLER BİYOLOJİ | |
dc.subject | Temel Bilimler | |
dc.subject | Biochemistry, Genetics and Molecular Biology (miscellaneous) | |
dc.subject | Clinical Biochemistry | |
dc.subject | Cancer Research | |
dc.subject | Pharmacology | |
dc.subject | Molecular Biology | |
dc.subject | Drug Discovery | |
dc.subject | Aging | |
dc.subject | General Biochemistry, Genetics and Molecular Biology | |
dc.subject | General Pharmacology, Toxicology and Pharmaceutics | |
dc.subject | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | |
dc.subject | Biochemistry | |
dc.subject | Structural Biology | |
dc.subject | Pharmacology (medical) | |
dc.subject | Pharmacy | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Eczacılık | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.title | An Expanding Role of Biomarkers in Pulmonary Arterial Hypertension | |
dc.type | Makale | |
dc.relation.journal | CURRENT PHARMACEUTICAL BIOTECHNOLOGY | |
dc.contributor.department | Bakirkoy Dr. Sadi Konuk Research & Training Hospital , , | |
dc.identifier.volume | 18 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 491 | |
dc.identifier.endpage | 494 | |
dc.contributor.firstauthorID | 239153 | |